Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-04-16

FDA Approved: ERLOTINIB — Original Application (Zydus Lifesciences Limited)

View source ↗

Summary

FDA approved a generic erlotinib product from Zydus Lifesciences Limited under an original ANDA submission.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ERLOTINIB (Erlotinib)

Snippet

ORIG AP for ERLOTINIB (ERLOTINIB)